Indication
Dermatofibrosarcoma protuberans
Dermatofibrosarcoma protuberans is a rare, low- to intermediate-grade cutaneous soft tissue sarcoma originating in the dermis and subcutaneous tissues. Read more about Dermatofibrosarcoma protuberans
28 drugs 27 manufacturers
Drugs that treat it
Common Dermatofibrosarcoma protuberans therapies.
IMATINIB MESYLATE
IMATINIB MESYLATE
IMATINIB MESYLATE
IMATINIB MESYLATE
IMATINIB MESYLATE
IMATINIB MESYLATE
IMATINIB MESYLATE
IMATINIB MESYLATE
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonDermatofibrosarcoma protuberans is a rare, low- to intermediate-grade cutaneous soft tissue sarcoma originating in the dermis and subcutaneous tissues.
Most frequently developing on the trunk and proximal extremities of young to middle-aged adults, it typically manifests as an indurated, slow-growing cutaneous plaque that eventually progresses into multinodular, violaceous or flesh-colored protuberant masses.
Pathophysiologically, more than 90% of cases are driven by a chromosomal translocation, t(17;22)(q22;q13), or supernumerary ring chromosomes that fuse the *COL1A1* and *PDGFB* genes, generating continuous autocrine activation of the platelet-derived growth factor receptor-beta pathway.
Histologically characterized by CD34-positive spindle cells arranged in a distinctive storiform pattern, the neoplasm demonstrates infiltrative, tentacle-like local growth patterns that yield high rates of local recurrence despite a low propensity for distant metastasis.
- nih.gov
Dermatofibrosarcoma protuberans is a rare, low- to intermediate-grade cutaneous soft tissue sarcoma originating in the dermis and subcutaneous tissues Most frequently developing on the trunk and proximal extremities of young to middle-aged adults, it typically manifests as an indurated, slow-growing cutaneous plaque that eventually progresses into multinodular, violaceous or flesh-colored protuberant masses
- cancerindex.org
Dermatofibrosarcoma protuberans is a rare, low- to intermediate-grade cutaneous soft tissue sarcoma originating in the dermis and subcutaneous tissues
- nih.gov
Dermatofibrosarcoma protuberans is a rare, low- to intermediate-grade cutaneous soft tissue sarcoma originating in the dermis and subcutaneous tissues Histologically characterized by CD34-positive spindle cells arranged in a distinctive storiform pattern, the neoplasm demonstrates infiltrative, tentacle-like local growth patterns that yield high rates of local recurrence despite a low propensity for distant metastasis
- medlineplus.gov
Most frequently developing on the trunk and proximal extremities of young to middle-aged adults, it typically manifests as an indurated, slow-growing cutaneous plaque that eventually progresses into multinodular, violaceous or flesh-colored protuberant masses
- nih.gov
Pathophysiologically, more than 90% of cases are driven by a chromosomal translocation, t(17;22)(q22;q13), or supernumerary ring chromosomes that fuse the *COL1A1* and *PDGFB* genes, generating continuous autocrine activation of the platelet-derived growth factor receptor-beta pathway
- nih.gov
Pathophysiologically, more than 90% of cases are driven by a chromosomal translocation, t(17;22)(q22;q13), or supernumerary ring chromosomes that fuse the *COL1A1* and *PDGFB* genes, generating continuous autocrine activation of the platelet-derived growth factor receptor-beta pathway Histologically characterized by CD34-positive spindle cells arranged in a distinctive storiform pattern, the neoplasm demonstrates infiltrative, tentacle-like local growth patterns that yield high rates of local re...
Personalize your experience
Follow Dermatofibrosarcoma protuberans and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.